Letter to the Editor: Unexpected gastrointestinal toxicity from Docetaxel/Carboplatin/Erlotinib followed by maintenance Erlotinib treatment for newly diagnosed stage III/IV ovarian cancer, primary peritoneal, or fallopian tube cancer
Ovarian Cancer and Us
OVARIAN CANCER and US
Ovarian Cancer and Us
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.